llp2a-alendronate
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 14, 2016 (NCT03197623)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- llp2a-alendronate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03197623 | Phase 1 | Oct 14, 2016 | California Institute for Regenerative Medicine, University of California, Davis |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Institute for Regenerative Medicine | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2016 |
2 organizations
Page 1 / 1